Current Issue

June 2013 | Volume 12 | Issue 6
Preadolescent Moderate Acne Vulgaris: A Randomized Trial of the Efficacy and Safety
of Topical Adapalene-Benzoyl Peroxides
Lawrence F. Eichenfield MD,a Zoe Draelos MD,b Anne W. Lucky MD,c Adelaide A. Hebert MD,d Jeffrey
Sugarman MD,e Linda Stein Gold MD,f Diane Rudisill BS,g Hong Liu MS,g and Vasant Manna MDg

A Phase IV, Open-Label Study Evaluating the Use of Triple-Combination Therapy With
Minocycline HCl Extended-Release Tablets, a Topical Antibiotic/Retinoid Preparation
and Benzoyl Peroxide in Patients With Moderate to Severe Acne Vulgaris
Andrea L. Zaenglein MD,a Ava Shamban MD,b Guy Webster MD PhD,c James Del Rosso DO FAOCD,d Jeffrey
S. Dover MD FRCPC,e Leonard Swinyer MD,fLinda Stein MD,g Xiaoming Lin MS RN,h Zoe Draelos
MD,i Michael Gold MD,jand Diane Thiboutot MDa

Clinical Relevance of Skin Barrier Changes Associated With the Use of Oral
Isotretinoin: The Importance of Barrier Repair Therapy in Patient Management
James Q. Del Rosso DO FAOCD

A Single-Center, Randomized Double-Blind, Parallel-Group Study to Examine the
Safety and Efficacy of 3mg Drospirenone/0.02mg Ethinyl Estradiol Compared With
Placebo in the Treatment of Moderate Truncal Acne Vulgaris
Ma. Beatrice Alora Palli MD,a,b Claire Marie Reyes-Habito MD,b Xinaida T. Lima MD MPH,c and Alexa B.
Kimball MD MPHa,b

40 Years of Topical Tretinoin Use in Review
Hilary E. Baldwin MD,a Marge Nighland BS,b Clare Kendall MA,c David A. Mays PharmD MBA,c Rachel
Grossman MD,b,c and Joan Newburger PhDc

Tolerability and Irritation Potential of Four Topical Acne Regimens in Healthy Subjects
Gary Grove PhD,a Charles Zerweck PhD,a and Jennifer Gwazdauskas MBAb

Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the
Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two
Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies
Joseph Fowler Jr. MD,a J. Mark Jackson MD,a Angela Moore MD,b Michael Jarratt MD,c Terry Jones
MD,d Kappa Meadows MD,eMartin Steinhoff MD,f Diane Rudisill BSc,g and Matthew Leoni MDg on behalf of the
Brimonidine Phase III Study Group

A Randomized, Phase 2, Dose-Ranging Study in the Treatment of Moderate to Severe
Inflammatory Facial Acne Vulgaris With Doxycycline Calcium
James J. Leyden MD,a Suzanne Bruce MD,b Chai Sue Lee MD,c,* Mark Ling MD PhD,d Pranav B. Sheth
MD,e Daniel M. Stewart DO,f William P. Werschler MD,g Richard D. Gilbert PhD,h and Leon Kircik MDi

Efficacy and Tolerability of Low Molecular Weight Hyaluronic Acid Sodium Salt 0.2%
Cream in Rosacea
Todd E. Schlesinger MD FAADa and Callie Rowland Powell BSN RNb

An Update on Super Wide Field Microscopy in Dermatologic Surgery
Nicholas B. Countryman MD MBA,a* Ross M. Levy MD,b, C.William Hanke MDa

Treatment of Bullous Pemphigoid With Rituximab: Critical Analysis of the Current
Literature
Shawn Shetty MD and A. Razzaque Ahmed MD DSc

Early Treatment With Nonsucrose Intravenous Immunoglobulin in a Burn Unit Reduces
Toxic Epidermal Necrolysis Mortality
Daniel J. Aires MD JD,a Garth Fraga MD,b Richard Korentager MD,c Coleman P. Richie MD,d Smita Aggarwal
MD,e Jo Wick PhD,fand Deede Y. Liu MDa

Vitiligo Surgical, Laser, and Alternative Therapies: A Review and Case Series
Cindy Wassef BA,a Adriana Lombardi MD,b Sairah Khokher MD,c and Babar K. Rao MDc

Open-Label Evaluation of a Novel Skin Brightening System Containing 0.01%
Decapeptide-12 in Combination With 20% Buffered Glycolic Acid for the Treatment of
Mild to Moderate Facial Melasma
Sandra P. Ramírez MD,a Alfonso C. Carvajal MD,b Juan C. Salazar MD,c Gladys Arroyave MD,d Ana M. Flórez
MD,e and Hector F. Echeverry MDf

IncobotulinumtoxinA in Esthetics
Martina Kerscher MD,a Yana Yutskovskaya MD,b and Timothy Corcoran Flynn MDc